We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

115 hedge funds and large institutions have $858M invested in Genomic Health, Inc. in 2013 Q2 according to their latest regulatory filings, with 115 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

55% less call options, than puts

Call options by funds: $2.69M | Put options by funds: $6M

Holders
115
Holders Change
+115
Holders Change %
–
% of All Funds
3.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
115
Increased
–
Reduced
–
Closed
–
Calls
$2.69M
Puts
$6M
Net Calls
-$3.31M
Net Calls Change
-$3.31M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$433M +$448M +13,650,835 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$67.1M +$69.5M +2,114,719 New
CIP
3
Champlain Investment Partners
Vermont
$30.6M +$31.7M +964,750 New
TGHSA
4
TPG Group Holdings (SBS) Advisors
Texas
$28.9M +$29.9M +910,273 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$26.3M +$27.2M +828,310 New
Lord, Abbett & Co
6
Lord, Abbett & Co
New Jersey
$21.4M +$22.2M +675,568 New
BFA
7
BlackRock Fund Advisors
California
$21M +$21.8M +662,327 New
State Street
8
State Street
Massachusetts
$19.8M +$20.6M +625,766 New
ICM
9
IronBridge Capital Management
Illinois
$18.3M +$19M +578,521 New
Baillie Gifford & Co
10
Baillie Gifford & Co
United Kingdom
$17M +$17.6M +535,910 New
BIT
11
BlackRock Institutional Trust
California
$16.5M +$17.1M +521,017 New
ACM
12
Apex Capital Management
Ohio
$12.6M +$13.1M +397,533 New
FWIA
13
Fort Washington Investment Advisors
Ohio
$9.33M +$9.66M +294,255 New
Mitsubishi UFJ Trust & Banking
14
Mitsubishi UFJ Trust & Banking
Japan
$8.74M +$9.05M +275,600 New
Northern Trust
15
Northern Trust
Illinois
$8.04M +$8.32M +253,408 New
TA
16
Teachers Advisors
New York
$6.73M +$6.97M +212,359 New
Norges Bank
17
Norges Bank
Norway
$6.4M +$6.63M +201,729 New
Goldman Sachs
18
Goldman Sachs
New York
$6.39M +$6.62M +201,414 New
PAMU
19
Pictet Asset Management (UK)
United Kingdom
$5.98M +$6.19M +188,600 New
Renaissance Technologies
20
Renaissance Technologies
New York
$5.3M +$5.49M +167,000 New
Millennium Management
21
Millennium Management
New York
$5.29M +$5.48M +166,835 New
State Farm Mutual Automobile Insurance
22
State Farm Mutual Automobile Insurance
Illinois
$4.62M +$4.79M +145,800 New
Morgan Stanley
23
Morgan Stanley
New York
$4.56M +$4.72M +143,848 New
TCIM
24
TIAA CREF Investment Management
New York
$3.75M +$3.89M +118,358 New
PP
25
PDT Partners
New York
$3.42M +$3.55M +108,002 New
1
2 3 4 5

GHDX Hedge Fund Activity: Q2 2013 in Review

115 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q2 2013, worth a combined $858M.

Buyers outnumbered sellers: 115 funds opened new GHDX positions and 0 closed out — a net gain of 115 holders — while 0 added to existing stakes and 0 trimmed.

  • 115 institutional investors held Genomic Health, Inc. (GHDX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $858M of Genomic Health, Inc. stock for Q2 2013.
  • 115 funds opened new Genomic Health, Inc. positions in Q2 2013 and 0 closed out, a net change of +115 holders.

Based on aggregated 13F filings for Q2 2013.